Skip to content

Efficacy of endoscopic submucosal dissection for gastrointestinal subepithelial tumors within the submucosa: multicenter study

Efficacy of endoscopic submucosal dissection for gastrointestinal subepithelial tumors within the submucosa: multicenter study - Endoscopic submucosal dissection for gastrointestinal subepithelial tumor within the submucosa

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011690
Enrollment
100
Registered
2013-11-01
Start date
2013-09-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal subepithelial tumors within submucosa

Interventions

endoscopic submucosal dissection:ESD

Sponsors

Kagawa University Hospital
Lead Sponsor
Ehime University Hospital, Kagawa Saiseikai hospital, Kochi Medical Center, Kochi Red Cross Hospital, Shimane Prefectural Central Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.lesion contained within the SM layer 2.all patients whom informed consents were obtained 3. symptomatic SET strongly suspected to be a benign tumor on conventional endoscopic imaging, EUS and computed tomography 4.Tumor with the increasing tendency of tumor size greater than 1.5 times the rate before 5. confirmed histological diagnosis of carcinoid tumor; carcinoid tumor 10 mm; no lymph node or distant metastasis found 6. Granular cell tumor confirmed by preoperative tissue diagnosis 7. Indefinite SMT which is suspected malignancy in the image preoperatively

Exclusion criteria

Exclusion criteria: 1.We exclude cysts, lipoma and vascular lesions with typical features in the image and asymptomatic symptoms 2.Lesions postoperative stenosis is expected, beyond the half cercumferential lumen 3.Lesions that can not check the remaining submucosa of the third layer by EUS 4.patients who do not meeting the following conditions: physical status I to II and normal complete blood cell counts and prothrombin times are excluded

Design outcomes

Primary

MeasureTime frame
en bloc rection rate

Secondary

MeasureTime frame
complications, procedure time, emergency,emergency surgery migration rate, additional surgery rate, recurrence rate, survival observation period

Countries

Japan

Contacts

Public ContactHideki Kobara

Kagawa University Hospital Gastroenterology and Neurology

kobara@med.kagawa-u.ac.jp087-898-5111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026